Ascendis Pharma A/S vs Alliant Energy Corporation — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Alliant Energy Corporation trades at $68.76 (market cap $17.78B). The key difference: Ascendis Pharma A/S and Alliant Energy Corporation are close in size by market cap, and Alliant Energy Corporation pays a 3.12% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | LNT | |
|---|---|---|
Market Cap | $16.67B | $17.78B |
Sector | Health | Utilities |
52-Week High | $277.18 | $78.03 |
52-Week Low | $189.74 | $63.62 |
Enterprise Value | $17.04B | $29.88B |
Dividend Yield | — | 3.12% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →